Clinical trial
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
NCT00399893 · Duke University, Other · Terminated
Key facts
| NCT number | NCT00399893 |
|---|---|
| Title | Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) |
| Official title | Investigation of the Developmental, Nutritional and Hormonal Regulation of Ghrelin in Children and Young Adults With Prader-Willi Syndrome (PWS): Octreotide Intervention Sub-study |
| Lead sponsor | Duke University, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Center for Research Resources (NCRR) Novartis Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Prader-Willi Syndrome |
| Intervention type | Drug |
| Interventions | Octreotide, Placebo |
| Enrollment | 5 |
| Start date | Dec 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Sep 1, 2010 |
| First posted | Nov 15, 2006 |
| Last update posted | Jul 24, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: